BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18632869)

  • 41. Replication licensing promotes cyclin D1 expression and G1 progression in untransformed human cells.
    Liu P; Slater DM; Lenburg M; Nevis K; Cook JG; Vaziri C
    Cell Cycle; 2009 Jan; 8(1):125-36. PubMed ID: 19106611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer.
    Kanda T; Onda T; Zanma S; Yasugi T; Furuno A; Watanabe S; Kawana T; Sugase M; Ueda K; Sonoda T
    Virology; 1992 Oct; 190(2):724-32. PubMed ID: 1325704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
    Hubert WG; Laimins LA
    J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colocalization of human papillomavirus type 11 E1[symbol: see text]E4 and L1 proteins in human foreskin implants grown in athymic mice.
    Brown DR; Fan L; Jones J; Bryan J
    Virology; 1994 May; 201(1):46-54. PubMed ID: 8178488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The human papillomavirus type 11 E1/\E4 protein is not essential for viral genome amplification.
    Fang L; Budgeon LR; Doorbar J; Briggs ER; Howett MK
    Virology; 2006 Aug; 351(2):271-9. PubMed ID: 16687161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uncovering the Role of the E1 Protein in Different Stages of Human Papillomavirus 18 Genome Replication.
    Piirsoo A; Kala M; Sankovski E; Ustav M; Piirsoo M
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.
    Biryukov J; Myers JC; McLaughlin-Drubin ME; Griffin HM; Milici J; Doorbar J; Meyers C
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29257050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The human papillomavirus type 11 E1--E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope.
    Brown DR; Kitchin D; Qadadri B; Neptune N; Batteiger T; Ermel A
    Virology; 2006 Feb; 345(1):290-8. PubMed ID: 16257432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomaviruses target the double-stranded RNA protein kinase pathway.
    Hebner CM; Wilson R; Rader J; Bidder M; Laimins LA
    J Gen Virol; 2006 Nov; 87(Pt 11):3183-3193. PubMed ID: 17030851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of human papillomaviruses in differentiating epithelia.
    Longworth MS; Laimins LA
    Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10.
    Ruesch MN; Stubenrauch F; Laimins LA
    J Virol; 1998 Jun; 72(6):5016-24. PubMed ID: 9573271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation
    Kuehner F; Wong M; Straub E; Doorbar J; Iftner T; Roden RBS; Stubenrauch F
    mBio; 2023 Aug; 14(4):e0069623. PubMed ID: 37382436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes.
    Jian Y; Schmidt-Grimminger DC; Chien WM; Wu X; Broker TR; Chow LT
    Oncogene; 1998 Oct; 17(16):2027-38. PubMed ID: 9798674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63.
    Šterbenc A; Hošnjak L; Chouhy D; Bolatti EM; Oštrbenk A; Seme K; Kocjan BJ; Luzar B; Giri AA; Poljak M
    PLoS One; 2017; 12(4):e0175892. PubMed ID: 28426749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification and biochemical characterization of the E1 replication initiation protein of the cutaneous human papillomavirus type 1.
    Sheikh S; Van Horn G; Naqvi A; Sheahan L; Khan SA
    J Gen Virol; 2003 Feb; 84(Pt 2):277-285. PubMed ID: 12560558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Replicative Consequences of Papillomavirus E2 Protein Binding to the Origin Replication Factor ORC2.
    DeSmet M; Kanginakudru S; Rietz A; Wu WH; Roden R; Androphy EJ
    PLoS Pathog; 2016 Oct; 12(10):e1005934. PubMed ID: 27701460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new cell culture model to genetically dissect the complete human papillomavirus life cycle.
    Bienkowska-Haba M; Luszczek W; Myers JE; Keiffer TR; DiGiuseppe S; Polk P; Bodily JM; Scott RS; Sapp M
    PLoS Pathog; 2018 Mar; 14(3):e1006846. PubMed ID: 29494681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virus-like particles and E1-E4 protein expressed from the human papillomavirus type 11 bicistronic E1-E4-L1 transcript.
    Brown DR; Pratt L; Bryan JT; Fife KH; Jansen K
    Virology; 1996 Aug; 222(1):43-50. PubMed ID: 8806486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
    Lee D; Sohn H; Kalpana GV; Choe J
    Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA.
    Bentley P; Tan MJA; McBride AA; White EA; Howley PM
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29848583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.